Repligen Corp (RGEN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Repligen Corp (RGEN)

RGEN 157.23

-2.8%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (154)	9/27/1999 2:32:00 PM
From: Pseudo Biologist	Read Replies (1) of 395

From the Acknowledgements of Storb et al: ... We thank Dr Peter Linsley, formerly of Bristol Myers Squibb Research, Seattle, WA, and now Rosetta Inphamatics, Kirkland, WA, for the gift of CTLA4IG; Dr Wen Chyi Shyu, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ, for measuring CTLA4Ig serum levels ... What's the IP situation here? Anyone knows? PB

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next